Trial Profile
The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis; Spinal cord injuries
- Focus Therapeutic Use
- 24 Feb 2014 New trial record